- Melanoma-Specific Antigens
- Accession Number
Cellular antigens that are specific for MELANOMA cells.
Drug Drug Description Melanoma antigen recognized by T-cells 1 Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).
- Drugs & Drug Targets
Drug Target Type